56. Behcet disease Clinical trials / Disease details
Clinical trials : 76 / Drugs : 110 - (DrugBank : 32) / Drug target genes : 36 - Drug target pathways : 116
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05032248 (ClinicalTrials.gov) | April 1, 2019 | 27/8/2021 | Uses of Tacrolimus in Behcet Disease | Uses of Tacrolimus in Treatment of Oral Ulcers in Behcet Disease | Oral Ulcer;Behcet Syndrome | Drug: Tacrolimus ointment | Assiut University | NULL | Completed | 18 Years | 70 Years | All | 40 | N/A | Egypt |